86 related articles for article (PubMed ID: 17406004)
21. Pharmacogenetics in the treatment of breast cancer.
Stearns V; Davidson NE; Flockhart DA
Pharmacogenomics J; 2004; 4(3):143-53. PubMed ID: 15024382
[No Abstract] [Full Text] [Related]
22. Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue.
Martinez V; Kennedy S; Doolan P; Gammell P; Joyce H; Kenny E; Prakash Mehta J; Ryan E; O'Connor R; Crown J; Clynes M; O'Driscoll L
Breast Cancer Res Treat; 2008 Aug; 110(3):521-30. PubMed ID: 17899366
[TBL] [Abstract][Full Text] [Related]
23. Translational research in breast cancer.
Chu QD; Holm N; Byrnes K; Li BD
Surg Oncol Clin N Am; 2008 Apr; 17(2):421-38, x. PubMed ID: 18375360
[TBL] [Abstract][Full Text] [Related]
24. Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.
Nuyten DS; van de Vijver MJ
Semin Radiat Oncol; 2008 Apr; 18(2):105-14. PubMed ID: 18314065
[TBL] [Abstract][Full Text] [Related]
25. [Has the time arrived for gene expression use at the bedside?].
D'Hondt V; Piccart M; Sotiriou C
Bull Cancer; 2008 Mar; 95(3):336-43. PubMed ID: 18390414
[TBL] [Abstract][Full Text] [Related]
26. Identification of differentially expressed genes by meta-analysis of microarray data on breast cancer.
Kondrakhin YV; Sharipov RN; Keld AE; Kolpakov FA
In Silico Biol; 2008; 8(5-6):383-411. PubMed ID: 19374127
[TBL] [Abstract][Full Text] [Related]
27. Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K; Miki Y
Breast Cancer; 2008; 15(2):117-20. PubMed ID: 18274834
[TBL] [Abstract][Full Text] [Related]
28. Personalized systemic treatment for breast cancer patients: is it a reality?
Shimizu C; Fujiwara Y
Breast Cancer; 2008; 15(2):141-4. PubMed ID: 18274835
[TBL] [Abstract][Full Text] [Related]
29. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
30. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
[TBL] [Abstract][Full Text] [Related]
31. Clinical validation of a customized multiple signature microarray for breast cancer.
Tan BK; Tan LK; Yu K; Tan PH; Lee M; Sii LH; Wong CY; Ho GH; Yeo AW; Chow PK; Koong HN; Yong WS; Lim DT; Ooi LL; Soo KC; Tan P
Clin Cancer Res; 2008 Jan; 14(2):461-9. PubMed ID: 18223220
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
33. Lost in translation--prognostic signatures for breast cancer.
Pusztai L
Nat Clin Pract Oncol; 2008 Jul; 5(7):363. PubMed ID: 18583992
[No Abstract] [Full Text] [Related]
34. Treatment of hereditary breast cancer.
Robson ME
Semin Oncol; 2007 Oct; 34(5):384-91. PubMed ID: 17920892
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer special types: why bother?
Reis-Filho JS; Lakhani SR
J Pathol; 2008 Dec; 216(4):394-8. PubMed ID: 18798222
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of breast cancer: toward the individualization of therapy.
Chang JC; Hilsenbeck SG; Fuqua SA
Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
[No Abstract] [Full Text] [Related]
37. Transcriptomic signatures in breast cancer.
Fu J; Jeffrey SS
Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
[TBL] [Abstract][Full Text] [Related]
38. Preoperative chemotherapy and potential impact on re-excision for early breast cancer.
Batsis H; Ignantiadou E; Harissis HV
Ann Surg Oncol; 2009 Oct; 16(10):2956-7; author reply 2958-9. PubMed ID: 19575266
[No Abstract] [Full Text] [Related]
39. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
40. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
